JP
Therapeutic Areas
Nanoform Finland Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Multiple Partnered Small Molecule Programs | Various (Oncology, CNS, Infectious Disease) | Pre-clinical to Phase 3 |
| Biologics Nanoforming Platform | Platform for peptides & proteins | Research |
| Inhaled & Pulmonary Delivery Programs | Respiratory & systemic delivery | Pre-clinical |
Leadership Team at Nanoform Finland
EH
Edward Haeggström
Chief Executive Officer (CEO), Co-founder
AH
Albert Hæggström
Chairman of the Board, Co-founder
GC
Gianni Ciofani
Chief Business Officer (CBO)
TL
Tommi Lehtonen
Chief Financial Officer (CFO)
CE
Christian Ekberg
Chief Technology Officer (CTO)
HA
Hélder A. Santos
Chief Scientific Officer (CSO)
EG
Erika Grönroos
VP, People & Culture
OK
Outi Kiviharju
VP, Legal & Compliance
SP
Sara Pereira
VP, Communications
RR
Riku Rantanen
Board Member